Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FTSE 250 movers: CVS jumps, oil stocks slip

(Sharecast News) - FTSE 250 (MCX) 23,412.10 1.06% Veterinary services provider CVS Group gained after saying it has successfully refinanced its bank debt facilities and announcing the launch of a £50m share buyback and the acquisition of a small animal practice in Australia.

The company said it has refinanced its £350m debt facilities on improved terms. This includes a term loan of £125m and a revolving credit facility of £225m, both repayable in May 2030, and the existing overdraft facility of £5m, renewable annually.

The margin payable on drawn debt has reduced by 20 basis points, CVS said. These new facilities are provided by a syndicate of eight banks, including Westpac Banking Corporation, the first Australian bank to join the group's financing syndicate. The group has an option to extend these facilities for a further year.

CVS said it has agreed to buy a further single site first opinion companion animal practice in Sydney for an initial consideration of AUD$8.2m (around £4m). It has also signed contracts for a further practice acquisition in Australia - for AUD3.2m (£1.7m) - with completion expected in the coming weeks.

Finally, CVS said that in light of the successful refinancing and consistent with its capital allocation priorities, the board has approved a share buyback programme to return up to £50m to shareholders.

Chief executive Richard Fairman said: "We are pleased to have refinanced our bank facilities through to May 2030 on improved terms. This provides additional flexibility and firepower to launch a meaningful share buyback programme, alongside disciplined capital allocation in enhancing our estate and quality of service to our customers and investing in our attractive pipeline of accretive acquisitions.

"We look forward to updating investors at the time of our full year trading update on how this approach underpins the delivery of shareholder returns."

Qinetiq was boosted by an upgrade to 'buy' from 'hold' at Peel Hunt.

Oil stocks were lower in line with a weaker oil price. Ithaca Energy and Harbour Energy both fell.

FTSE 250 - Risers

CVS Group (CVSG) 1,276.00p 6.34% Pan African Resources (PAF) 142.50p 6.11% SSP Group (SSPG) 172.60p 5.18% The Schiehallion Fund Limited NPV (MNTN) 2.14p 4.63% Johnson Service Group (JSG) 143.10p 4.08% Endeavour Mining (EDV) 4,459.00p 4.01% BlackRock World Mining Trust (BRWM) 1,004.00p 3.95% Hochschild Mining (HOC) 596.00p 3.93% Mitchells & Butlers (MAB) 239.50p 3.68% Raspberry PI Holdings (RPI) 776.50p 3.64%

FTSE 250 - Fallers

AEP Plantations (AEP) 1,736.00p -6.23% Ithaca Energy (ITH) 237.40p -2.26% C&C Group (CDI) (CCR) 105.80p -2.22% Harbour Energy (HBR) 277.40p -2.11% Kainos Group (KNOS) 859.00p -1.99% Hilton Food Group (HFG) 548.00p -1.70% Tate & Lyle (TATE) 499.60p -1.67% Cranswick (CWK) 5,450.00p -1.27% Diversified Energy Company (DI) (DEC) 1,130.00p -1.22% Spire Healthcare Group (SPI) 220.00p -1.12%

Share this article

Related Sharecast Articles

FTSE 100 movers: Retailers rally, oil giants gush lower
(Sharecast News) - London's FTSE 100 was flat at 10,487.29 in afternoon trade on Wednesday.
FTSE 100 movers: Kingfisher gains on results; Melrose slides after chemical incident
(Sharecast News) - London's FTSE 100 was up 0.6% at 10,526.99 in afternoon trade on Tuesday.
FTSE 250 movers: Bodycote, Ceres Power surge; Genuit slips
(Sharecast News) - FTSE 250 (MCX) 23,141.59 0.84%

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.